Go to main cotent

product image

  • product image

Prescription Drugs Prescription Drugs

GreenGene F inj.

  • Effects
    Bleeding symptom control and hemostasis for persons with hemophilia A
  • Description & Ingredients
    Blood coagulation factor VIII, recombinant & White or light yellow powder, odorless, colorless and transparent vials
Characteristics

GreenGene F (INN: beroctocog alfa) is a third-generation recombinant factor VIII newly developed to treat hemophilia A patients.

Through various improvements, GreenGene F now offers a significantly reduced risk of transmission of viral pathogens and is

regarded as being of higher quality than its current competitors.

Ingredients

1 vial (500 I.U. or 1000 I.U.) contains

Active Ingredients

-Beroctocog alfa (Antihemophilic factor VIII, recombinant)....................500 I.U. or 1000 I.U.

Inactive Ingredient

-Buffer: L-Histidine.......................................31.0mg

-Isotonizer: Sodium chloride.........................35.0mg

-Stabilizer: Polyethylene glycol 3350………..4.0mg

                   L-Arginine Hydrochloride………29.5mg

                   L-Glutamic Acid………………...33.6mg

                   L-Isoleucine……………………...3.7mg

                   Calcium Chloride 2 Hydrate……..2.4mg

                    Polysorbate 80……………………0.4mg

Effects

· GreenGene F is indicated in Hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes and preoperative management. GreenGene F is not indicated for the treatment of von Willebrand’s disease.

Usage/Dosage

· GreenGene F is administered by IV infusion after reconstitution of lyophilized powder with water for injection (4mL, provided).

After reconstitution, GreenGene F should be injected intravenously over several minutes.

Dosage should be consulted with physician.

Precaution for use

· For administration precautions, please click the Download Manual button.

Quantity per pack

· 500 IU

· 1,000 IU

Other

· Store at 2~8 ℃ in hermetic container. 

· Shelf life: 24 months from the date of manufacture

이메일집단수집거부

GC녹십자는 이메일 수집을 거부합니다

본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나
그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,
이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을
유념하시기 바랍니다

게시일: 2003년 9월 1일